Cargando…

A Clinical Update on SARS-CoV-2: Pathology and Development of Potential Inhibitors

SARS-CoV-2 (severe acute respiratory syndrome) is highly infectious and causes severe acute respiratory distress syndrome (SARD), immune suppression, and multi-organ failure. For SARS-CoV-2, only supportive treatment options are available, such as oxygen supportive therapy, ventilator support, antib...

Descripción completa

Detalles Bibliográficos
Autores principales:	Singh, Desh Deepak, Han, Ihn, Choi, Eun-Ha, Yadav, Dharmendra Kumar
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	MDPI 2023
Materias:	Review
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9857284/ https://www.ncbi.nlm.nih.gov/pubmed/36661514 http://dx.doi.org/10.3390/cimb45010028

Ejemplares similares

Current Potential Therapeutic Approaches against SARS-CoV-2: A Review
por: Yadav, Dharmendra Kumar, et al.
Publicado: (2021)

Immunopathology, host-virus genome interactions, and effective vaccine development in SARS-CoV-2
por: Singh, Desh Deepak, et al.
Publicado: (2020)

Recent Advances in Pathophysiology, Drug Development and Future Perspectives of SARS-CoV-2
por: Singh, Desh Deepak, et al.
Publicado: (2020)

SARS-CoV-2: Emergence of New Variants and Effectiveness of Vaccines
por: Singh, Desh Deepak, et al.
Publicado: (2021)

Corrigendum: SARS-CoV-2: Emergence of New Variants and Effectiveness of Vaccines
por: Singh, Desh Deepak, et al.
Publicado: (2022)

CRISPR/Cas9 based genome editing for targeted transcriptional control in triple-negative breast cancer
por: Deepak Singh, Desh, et al.
Publicado: (2021)

SARS-CoV-2: Recent Variants and Clinical Efficacy of Antibody-Based Therapy
por: Singh, Desh Deepak, et al.
Publicado: (2022)

Clinical updates on tyrosine kinase inhibitors in HER2-positive breast cancer
por: Singh, Desh Deepak, et al.
Publicado: (2022)

Clinical Significance of MicroRNAs, Long Non-Coding RNAs, and CircRNAs in Cardiovascular Diseases
por: Singh, Desh Deepak, et al.
Publicado: (2023)

TNBC: Potential Targeting of Multiple Receptors for a Therapeutic Breakthrough, Nanomedicine, and Immunotherapy
por: Singh, Desh Deepak, et al.
Publicado: (2021)

Development of Dementia in Type 2 Diabetes Patients: Mechanisms of Insulin Resistance and Antidiabetic Drug Development
por: Singh, Desh Deepak, et al.
Publicado: (2022)

Role of PARP in TNBC: Mechanism of Inhibition, Clinical Applications, and Resistance
por: Singh, Desh Deepak, et al.
Publicado: (2021)

Review of Developments in Combating COVID-19 by Vaccines, Inhibitors, Radiations, and Nonthermal Plasma
por: Han, Ihn, et al.
Publicado: (2022)

Nonthermal Biocompatible Plasma Inactivation of Coronavirus SARS-CoV-2: Prospects for Future Antiviral Applications
por: Han, Ihn, et al.
Publicado: (2022)

Recent Clinical Advances on Long Non-Coding RNAs in Triple-Negative Breast Cancer
por: Singh, Desh Deepak, et al.
Publicado: (2023)

Rapid diagnostic methods for SARS-CoV-2 (COVID-19) detection: an evidence-based report
por: Verma, Manish Kumar, et al.
Publicado: (2021)

Humoral Immune Response of SARS-CoV-2 Infection and Anti-SARS-CoV-2 Vaccination in Renal Transplant Recipients
por: Prasad, Narayan, et al.
Publicado: (2022)

An update on SARS-CoV-2 immunization and future directions
por: Rana, Rashmi, et al.
Publicado: (2023)

RAGE Inhibitors for Targeted Therapy of Cancer: A Comprehensive Review
por: Faruqui, Tabrez, et al.
Publicado: (2022)

SARS-CoV-2: An Update on Potential Antivirals in Light of SARS-CoV Antiviral Drug Discoveries
por: Elshabrawy, Hatem A.
Publicado: (2020)

An Update on the Current State of SARS-CoV-2 Mac1 Inhibitors
por: O’Connor, Joseph J., et al.
Publicado: (2023)

Inactivation of Infectious Bacteria Using Nonthermal Biocompatible Plasma Cabinet Sterilizer
por: Akter, Mahmuda, et al.
Publicado: (2020)

Transmission Cycle of SARS-CoV and SARS-CoV-2
por: Yadav, Tushar, et al.
Publicado: (2020)

Correction to: Transmission Cycle of SARS-CoV and SARS-CoV-2
por: Yadav, Tushar, et al.
Publicado: (2020)

An update on SARS-CoV-2/COVID-19 with particular reference to its clinical pathology, pathogenesis, immunopathology and mitigation strategies
por: Dhama, Kuldeep, et al.
Publicado: (2020)

Update on Functional Inhibitors of Acid Sphingomyelinase (FIASMAs) in SARS-CoV-2 Infection
por: Loas, Gwenolé, et al.
Publicado: (2021)

Molecular Advances in SARS-CoV-2: A Brief Update on Transmission, Infection, and Pathology Aspects
por: Mesquita, João R.
Publicado: (2022)

Updated Approaches against SARS-CoV-2
por: Li, Haiou, et al.
Publicado: (2020)

Update on Neurological Manifestations of SARS-CoV-2
por: Valiuddin, Hisham M., et al.
Publicado: (2020)

Updates in Management of SARS-CoV-2 Infection
por: Flisiak, Robert, et al.
Publicado: (2022)

Identification of intrinsically disorder regions in non-structural proteins of SARS-CoV-2: New insights into drug and vaccine resistance
por: Anjum, Farah, et al.
Publicado: (2022)

Data mining of coronavirus: SARS-CoV-2, SARS-CoV and MERS-CoV
por: Huh, Jung Eun, et al.
Publicado: (2021)

Repurposing and computational design of PARP inhibitors as SARS-CoV-2 inhibitors
por: Rampogu, Shailima, et al.
Publicado: (2023)

Cold atmospheric plasma generated reactive species aided inhibitory effects on human melanoma cells: an in vitro and in silico study
por: Yadav, Dharmendra Kumar, et al.
Publicado: (2020)

Inactivation of SARS-CoV-2 by gamma irradiation
por: Jain, Rajlaxmi, et al.
Publicado: (2021)

A potential role for AHR in SARS-CoV-2 pathology
por: Giovannoni, Federico, et al.
Publicado: (2020)

SARS-CoV-2 and pancreas: a potential pathological interaction?
por: Geravandi, Shirin, et al.
Publicado: (2021)

In-silico design of a potential inhibitor of SARS-CoV-2 S protein
por: Jaiswal, Grijesh, et al.
Publicado: (2020)

SARS-CoV-2 Infection and Placental Pathology
por: Leal, Caio Ribeiro Vieira, et al.
Publicado: (2021)

Methylxanthines as Potential Inhibitor of SARS-CoV-2: an In Silico Approach
por: Rolta, Rajan, et al.
Publicado: (2022)

Cannot write session to /tmp/vufind_sessions/sess_9gekmeb07qk63c0vt2os3d5vr3